Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:21135546rdf:typepubmed:Citationlld:pubmed
pubmed-article:21135546lifeskim:mentionsumls-concept:C0262950lld:lifeskim
pubmed-article:21135546lifeskim:mentionsumls-concept:C0149721lld:lifeskim
pubmed-article:21135546lifeskim:mentionsumls-concept:C0022661lld:lifeskim
pubmed-article:21135546lifeskim:mentionsumls-concept:C0403447lld:lifeskim
pubmed-article:21135546lifeskim:mentionsumls-concept:C0061928lld:lifeskim
pubmed-article:21135546lifeskim:mentionsumls-concept:C0962301lld:lifeskim
pubmed-article:21135546lifeskim:mentionsumls-concept:C0678715lld:lifeskim
pubmed-article:21135546pubmed:issue1-3lld:pubmed
pubmed-article:21135546pubmed:dateCreated2011-1-13lld:pubmed
pubmed-article:21135546pubmed:abstractTextLeft ventricular hypertrophy (LVH) is a major cardiovascular complication in chronic kidney disease (CKD) patients. For a successful management of LVH, the comprehensive understanding of the classical and the new emerging factors associated with LVH is of paramount importance. The aim of the present study was to evaluate the clinical correlates of bone mineral metabolism with the occurrence of LVH in nondialyzed CKD patients.lld:pubmed
pubmed-article:21135546pubmed:languageenglld:pubmed
pubmed-article:21135546pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21135546pubmed:citationSubsetIMlld:pubmed
pubmed-article:21135546pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21135546pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21135546pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21135546pubmed:statusMEDLINElld:pubmed
pubmed-article:21135546pubmed:issn1421-9735lld:pubmed
pubmed-article:21135546pubmed:authorpubmed-author:HigaAAlld:pubmed
pubmed-article:21135546pubmed:authorpubmed-author:DraibeS ASAlld:pubmed
pubmed-article:21135546pubmed:authorpubmed-author:CarvalhoA BABlld:pubmed
pubmed-article:21135546pubmed:authorpubmed-author:CanzianiM E...lld:pubmed
pubmed-article:21135546pubmed:authorpubmed-author:TomiyamaCClld:pubmed
pubmed-article:21135546pubmed:copyrightInfoCopyright © 2010 S. Karger AG, Basel.lld:pubmed
pubmed-article:21135546pubmed:issnTypeElectroniclld:pubmed
pubmed-article:21135546pubmed:volume31lld:pubmed
pubmed-article:21135546pubmed:ownerNLMlld:pubmed
pubmed-article:21135546pubmed:authorsCompleteYlld:pubmed
pubmed-article:21135546pubmed:pagination26-32lld:pubmed
pubmed-article:21135546pubmed:meshHeadingpubmed-meshheading:21135546...lld:pubmed
pubmed-article:21135546pubmed:meshHeadingpubmed-meshheading:21135546...lld:pubmed
pubmed-article:21135546pubmed:meshHeadingpubmed-meshheading:21135546...lld:pubmed
pubmed-article:21135546pubmed:meshHeadingpubmed-meshheading:21135546...lld:pubmed
pubmed-article:21135546pubmed:meshHeadingpubmed-meshheading:21135546...lld:pubmed
pubmed-article:21135546pubmed:meshHeadingpubmed-meshheading:21135546...lld:pubmed
pubmed-article:21135546pubmed:meshHeadingpubmed-meshheading:21135546...lld:pubmed
pubmed-article:21135546pubmed:meshHeadingpubmed-meshheading:21135546...lld:pubmed
pubmed-article:21135546pubmed:meshHeadingpubmed-meshheading:21135546...lld:pubmed
pubmed-article:21135546pubmed:meshHeadingpubmed-meshheading:21135546...lld:pubmed
pubmed-article:21135546pubmed:meshHeadingpubmed-meshheading:21135546...lld:pubmed
pubmed-article:21135546pubmed:year2011lld:pubmed
pubmed-article:21135546pubmed:articleTitleFibroblast growth factor 23 in chronic kidney disease: bridging the gap between bone mineral metabolism and left ventricular hypertrophy.lld:pubmed
pubmed-article:21135546pubmed:affiliationNephrology Division, Department of Medicine, Federal University of São Paulo, São Paulo, Brazil. dialisefor@uol.com.brlld:pubmed
pubmed-article:21135546pubmed:publicationTypeJournal Articlelld:pubmed
entrez-gene:8074entrezgene:pubmedpubmed-article:21135546lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:21135546lld:entrezgene